Mylan reports double-digit growth in first quarter of 2017

Mylan has announced its financial results for the first quarter of 2017, during which it delivered a revenue total of $2.72 billion (2.11 billion pounds).

This represents a year-on-year increase of 24 percent, with a solid performance in North America and robust double-digit growth in Europe and the rest of the world.

The recent acquisitions of Meda and the non-sterile, topicals-focused business of Renaissance Acquisition Holdings helped to contribute to this encouraging momentum, offsetting a net decrease in sales from new and existing products.

Based on this data, Mylan is anticipating another year of strong financial performance and has confirmed its guidance and business outlook for 2017, including its adjusted earnings per share guidance range.

Mid-single digit price-erosion is still expected for 2017 on a global basis, with Mylan remaining committed to deleveraging during the year.

Heather Bresch, chief executive officer of Mylan, said: "These results are a true reflection of all of the great assets we have integrated, with significant contributions from acquisitions completed last year, as well as from new product launches across our business."

With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.